Lymphoscintigraphy of the pretreated neck in head and neck squamous cell carcinoma

Lymphoscintigraphy of the pretreated neck in head and neck squamous cell carcinoma - PRET study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30277

Enrollment

Registered

2006-11-10

Start date

2006-10-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer head and neck squaumous cell carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: recurrent or scond primary head and neck cancer suitable for peritumoral injection previous treatment of lymph nodes clinically N0 neck

Exclusion criteria

Exclusion criteria: age 80years

Design outcomes

Primary

Measure	Time frame
Primary endpoint is the lymph node drainage of recurrent or second primary HNSCC in the previously treated neck.	—

Secondary

Measure	Time frame
Secondary endpoints are alteration of lymphatic drainage after previous treatment of the neck and influence of lymph node mapping (and sentinel node biopsy or cytology) on treatment planning.	—

Countries

Netherlands

Outcome results